Molecular Biology of the Lung: Volume I: Emphysema and Infection: Respiratory Pharmacology and Pharmacotherapy
Editat de Robert Stockleyen Limba Engleză Paperback – 14 oct 2012
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (2) | 358.98 lei 43-57 zile | |
Birkhäuser Basel – 16 oct 2012 | 358.98 lei 43-57 zile | |
Birkhäuser Basel – 14 oct 2012 | 359.35 lei 43-57 zile | |
Hardback (2) | 638.70 lei 43-57 zile | |
Birkhauser Basel – 30 noi 1998 | 638.70 lei 43-57 zile | |
Birkhauser – 30 noi 1998 | 639.05 lei 43-57 zile |
Preț: 359.35 lei
Preț vechi: 378.26 lei
-5% Nou
Puncte Express: 539
Preț estimativ în valută:
68.77€ • 71.44$ • 57.13£
68.77€ • 71.44$ • 57.13£
Carte tipărită la comandă
Livrare economică 03-17 februarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783034897914
ISBN-10: 303489791X
Pagini: 228
Ilustrații: VIII, 216 p.
Greutate: 0.37 kg
Ediția:1999
Editura: Birkhäuser Basel
Colecția Birkhäuser
Seria Respiratory Pharmacology and Pharmacotherapy
Locul publicării:Basel, Switzerland
ISBN-10: 303489791X
Pagini: 228
Ilustrații: VIII, 216 p.
Greutate: 0.37 kg
Ediția:1999
Editura: Birkhäuser Basel
Colecția Birkhäuser
Seria Respiratory Pharmacology and Pharmacotherapy
Locul publicării:Basel, Switzerland
Public țintă
ResearchCuprins
1. Application of Transgenic and Gene-Targeted Mice to Dissect Mechanisms of Lung Disease.- Emphysema.- 2. Models of Genetic Emphysema: The C57B1/6J Mice and their Mutants: Tight-Skin, Pallid and Beige Giuseppe Lungarella, Eleonora Cavarra and.- 3. ?1-Antitrypsin Deficiency.- 4. Recombinant SLPI: Emphysema and Asthma.- 5. Elastase Inhibitors in the Lung: Expression and Functional Relationships.- 6. Regulation of Neutrophil Proteinases.- 7. Control of Connective Tissue Genes.- Infection.- 8. Genetic Models of Bacterial Lung Infection.- 9. Genetics of Bacteria: Role in Pathogenesis of Infection of the Respiratory Tract.- 10. Polymerase Chain Reaction in the Diagnosis of Respiratory Tract Infections.- 11. Cystic Fibrosis.- 12. Respiratory Bacterial Infections in Patients with Cystic Fibrosis: Pathogenicity and Implications for Serine Proteinase Inhibitor Therapy.